Target intelligence / Profile preview

Zika virus non-structural protein 1 (NS1) (NS1)

Target
NS1
Molecular classification
Viral protein, Non-structural protein
01

Overview

The Zika virus non-structural protein 1 (NS1) is a ~48-50 kDa glycoprotein essential for the flavivirus lifecycle, functioning primarily in the endoplasmic reticulum (ER) lumen where it exists as a homodimer. NS1 remodels ER membranes by inserting hydrophobic regions, such as the N-terminal β-roll and flexible loops, into the inner leaflet to induce perinuclear aggregation and form convoluted networks resembling viral replication compartments, which are critical for RNA synthesis and viral amplification. This membrane-binding and curvature-altering activity depends on specific motifs like the greasy finger and wing domains, enabling NS1 to create invaginations without direct contact with cytoplasmic replication machinery. Secreted as a hexameric lipoprotein, NS1 modulates host immune responses, interacts with glycoproteins like prM and E for virion production, and contributes to pathogenesis by evading innate immunity. Crystal structures (e.g., PDB 5K6K) reveal an elongated hydrophobic surface for membrane association and a variable polar outer face with glycosylation sites, distinguishing Zika NS1 from homologs like dengue NS1 in insertion depth and cholesterol affinity. As a validated therapeutic target, inhibiting NS1's ER remodeling or secretion could block Zika replication, though no approved drugs exist.

Other names
Zika NS1ZIKV NS1
02

Biological functions

Genome replicationER membrane remodelingHost immune evasionViral RNA amplificationReplication compartment formation
03

Disease associations

Infection (Zika virus infection)Pathogenesis

Beyond the preview

Go deeper on Zika virus non-structural protein 1 (NS1) (NS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zika virus non-structural protein 1 (NS1) (NS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call